180 Life Sciences Corp. Files 8-K/A Amendment
Ticker: FRMM · Form: 8-K/A · Filed: Jun 30, 2025 · CIK: 1690080
| Field | Detail |
|---|---|
| Company | 180 Life Sciences CORP. (FRMM) |
| Form Type | 8-K/A |
| Filed Date | Jun 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, corporate-governance, material-agreement
Related Tickers: ATNF
TL;DR
180 Life Sciences filed an 8-K/A amendment covering exec changes and deal terminations.
AI Summary
180 Life Sciences Corp. filed an amendment (8-K/A) on June 30, 2025, to a report originally dated June 12, 2025. The amendment addresses the entry into and termination of material definitive agreements, departure of directors, election of directors, appointment of officers, and compensatory arrangements. It also includes other events and financial statements/exhibits.
Why It Matters
This amendment provides updated information on significant corporate events, including changes in leadership and contractual agreements, which could impact the company's strategic direction and operations.
Risk Assessment
Risk Level: medium — Amendments to 8-K filings often indicate significant corporate events that can introduce uncertainty or signal changes in business strategy.
Key Players & Entities
- 180 Life Sciences Corp. (company) — Filer of the 8-K/A amendment
- June 12, 2025 (date) — Earliest event reported date
- June 30, 2025 (date) — Filing date of the amendment
- KBL MERGER CORP. IV (company) — Former company name
FAQ
What specific material definitive agreements were entered into and subsequently terminated by 180 Life Sciences Corp.?
The filing indicates the entry into and termination of material definitive agreements, but the specific details of these agreements are not provided in the provided text.
Who are the directors or officers whose departure, election, or appointment is being reported in this amendment?
The filing mentions the departure of directors, election of directors, and appointment of certain officers, but the names of the individuals involved are not specified in the provided text.
What compensatory arrangements for certain officers are detailed in this filing?
The filing notes compensatory arrangements for certain officers, but the specifics of these arrangements are not included in the provided text.
What is the significance of the 'Other Events' item listed in the 8-K/A filing?
The 'Other Events' item suggests that there are additional material events that 180 Life Sciences Corp. is reporting beyond the standard categories, but the nature of these events is not detailed in the provided text.
Why is 180 Life Sciences Corp. filing an amendment (8-K/A) instead of a new 8-K?
An 8-K/A is filed to amend or supplement a previously filed 8-K report, indicating that the company is correcting or adding information to a prior filing.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on June 30, 2025 regarding 180 Life Sciences Corp. (FRMM).